Condition
Next Generation Sequencing
Total Trials
5
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown5
Clinical Trials (5)
Showing 5 of 5 trials
NCT06030869Unknown
MyCustom:Prospective Master Protocol Trial on Precision Medicine Treatment for Refractory Solid Tumors
NCT04955756Not ApplicableUnknown
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
NCT04574752Unknown
MSSA and MRSA Screening in Patients Undergoing Elective TJA: the Benefits of Next-generation Sequencing
NCT03953638UnknownPrimary
Application of Next Generation Sequencing Technique in Pediatric Bacterial Meningitis
NCT03232242UnknownPrimary
Application of NGS Technique in Precise Diagnosis of Infectious Diseases
Showing all 5 trials